Li Fu

11.7k total citations · 3 hit papers
242 papers, 8.8k citations indexed

About

Li Fu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Li Fu has authored 242 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Molecular Biology, 61 papers in Cancer Research and 49 papers in Oncology. Recurrent topics in Li Fu's work include Cancer-related gene regulation (34 papers), Epigenetics and DNA Methylation (34 papers) and RNA modifications and cancer (32 papers). Li Fu is often cited by papers focused on Cancer-related gene regulation (34 papers), Epigenetics and DNA Methylation (34 papers) and RNA modifications and cancer (32 papers). Li Fu collaborates with scholars based in China, Hong Kong and United States. Li Fu's co-authors include Xin‐Yuan Guan, Tuxiong Huang, Ehud Lavi, Canhua Huang, Zhao Huang, Na Xie, Dan Xie, Guobo Shen, Wei Gao and Leilei Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Li Fu

233 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoantigens: promising targets for cancer therapy

2023 536 citations Li Fu et al. profile →
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

2022 152 citations Li Fu et al. profile →
Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples

2024 54 citations Li Fu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li Fu China	52	5.2k	2.4k	2.1k	1.4k	766	242	8.8k
Peter E. Lobie China	58	5.2k 1.0×	2.8k 1.2×	2.4k 1.1×	952 0.7×	621 0.8×	233	9.4k
Jin Cheng China	43	4.2k 0.8×	1.4k 0.6×	2.1k 1.0×	980 0.7×	888 1.2×	118	7.5k
Hongbing Zhang China	49	5.6k 1.1×	1.6k 0.7×	1.5k 0.7×	1.1k 0.8×	817 1.1×	197	9.2k
Manuel Collado Spain	34	5.8k 1.1×	1.4k 0.6×	2.4k 1.1×	1.5k 1.1×	498 0.7×	78	9.2k
William P. Schiemann United States	59	6.8k 1.3×	2.4k 1.0×	3.5k 1.7×	1.3k 0.9×	1.3k 1.7×	132	11.1k
Kazuyoshi Yanagihara Japan	49	5.0k 1.0×	1.7k 0.7×	2.2k 1.0×	864 0.6×	1.1k 1.4×	215	7.8k
Levon M. Khachigian Australia	54	6.2k 1.2×	1.7k 0.7×	1.1k 0.5×	1.5k 1.1×	720 0.9×	207	9.9k
Ingrid Herr Germany	50	6.6k 1.3×	2.1k 0.9×	3.0k 1.4×	1.8k 1.3×	570 0.7×	139	10.2k
David K. Ann United States	52	5.0k 1.0×	2.0k 0.9×	1.9k 0.9×	873 0.6×	836 1.1×	171	8.3k
Cun‐Yu Wang United States	57	6.6k 1.3×	2.0k 0.9×	1.8k 0.9×	1.6k 1.1×	561 0.7×	115	10.8k

Countries citing papers authored by Li Fu

Since Specialization

Citations

This map shows the geographic impact of Li Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Fu more than expected).

Fields of papers citing papers by Li Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Fu. The network helps show where Li Fu may publish in the future.

Co-authorship network of co-authors of Li Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Fu. A scholar is included among the top collaborators of Li Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Fu. Li Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Xinyi, Zhen Wang, Li Fu, et al.. (2025). Dietary sugar intervention: A promising approach for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189402–189402.

Wang, Hua, Li Fu, Qi Wang, et al.. (2024). Simple isomeric pyridine-based fluorescence-off probes for in vitro monitoring γ-glutamyltranspeptidase activity: Design, synthesis and application. Dyes and Pigments. 228. 112252–112252. 1 indexed citations

Fu, Li, et al.. (2024). Interactions between deep eutectic solvents and bovine serum albumin studied by spectroscopic and electrochemical methods. Journal of Molecular Liquids. 410. 125519–125519. 4 indexed citations

Yang, Yang, Mengting Yu, Li Fu, et al.. (2023). Based on virtual screening methods and biological activity assessment, AK-968/13030056 has been identified as a potential mTOR inhibitor. Journal of Molecular Structure. 1302. 137425–137425. 4 indexed citations

Li, Xuemei, Xin Zeng, Jian Jiang, et al.. (2023). Krüppel-like factor 4 (KLF4) facilitates lipid production in immortalized human sebocytes via regulating the expression of SREBP1. Biochemical and Biophysical Research Communications. 667. 146–152. 5 indexed citations

Chen, Yú, Jian Li, ‪Shuyuan Zhang, et al.. (2022). Genetic risk of hyperuricemia in hypertensive patients associated with antihypertensive drug therapy: A longitudinal study. Clinical Genetics. 101(4). 411–420. 5 indexed citations

Huang, Tuxiong, Xiangyu Tan, Yuting Li, et al.. (2021). Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity. Gut. 71(2). 333–344. 142 indexed citations

Fu, Li, et al.. (2021). The role of myeloid‐derived suppressor cells in gastrointestinal cancer. Cancer Communications. 41(6). 442–471. 28 indexed citations

Xiang, Ying, Kai Yan, Qian Zheng, et al.. (2018). Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1. Cancer Research. 79(1). 86–98. 29 indexed citations

10.

Chen, Xiaohua, Xin Shi, Wenjun Xiong, et al.. (2018). E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the EGFR and c-MET Oncogenes by Destabilizing the Histone Demethylase KDM5C. Cancer Research. 78(6). 1418–1430. 57 indexed citations

11.

Tang, Kwan Ho, Yong Dai, Man Tong, et al.. (2013). A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer. Cancer Research. 73(7). 2322–2332. 128 indexed citations

12.

Fu, Li, Leilei Chen, Yanru Qin, et al.. (2013). Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Research. 73(7). 2298–2309. 51 indexed citations

13.

Tong, Man, Kwok Wah Chan, Jessie Y.J. Bao, et al.. (2012). Rab25 Is a Tumor Suppressor Gene with Antiangiogenic and Anti-Invasive Activities in Esophageal Squamous Cell Carcinoma. Cancer Research. 72(22). 6024–6035. 96 indexed citations

14.

Li, Yan, Leilei Chen, Tingting Zeng, et al.. (2011). Downregulation of RBMS3 Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Research. 71(19). 6106–6115. 48 indexed citations

15.

Qin, Yanru, Hong Tang, Fajun Xie, et al.. (2010). Characterization of Tumor-Suppressive Function of SOX6 in Human Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 17(1). 46–55. 57 indexed citations

16.

Kong, Kar Lok, Dora L.�W. Kwong, Li Fu, et al.. (2010). Characterization of a Candidate Tumor Suppressor Gene Uroplakin 1A in Esophageal Squamous Cell Carcinoma. Cancer Research. 70(21). 8832–8841. 38 indexed citations

17.

Li, Yan, Liang Hu, Yanru Qin, et al.. (2010). Characterization of a Novel Mechanism of Genomic Instability Involving the SEI1/SET/NM23H1 Pathway in Esophageal Cancers. Cancer Research. 70(14). 5695–5705. 25 indexed citations

18.

Zhang, Chunyu, Li Fu, Jianhua Fu, et al.. (2009). Fibroblast Growth Factor Receptor 2–Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma. Clinical Cancer Research. 15(12). 4017–4027. 95 indexed citations

19.

Ma, Ning-Fang, Sze Hang Lau, Liang Hu, et al.. (2008). COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis. Clinical Cancer Research. 14(16). 5061–5068. 132 indexed citations

20.

Chua, Daniel, Mandy Ng, Li Fu, et al.. (2006). High-throughput Loss-of-Heterozygosity Study of Chromosome 3p in Lung Cancer Using Single-Nucleotide Polymorphism Markers. Cancer Research. 66(8). 4133–4138. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact